Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Mallinckrodt
Johnson and Johnson
McKinsey
Boehringer Ingelheim

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Sulodexide

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Sulodexide: Patents, clinical trial progress, indications

Sulodexide is an investigational drug.

There have been 13 clinical trials for Sulodexide. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2015.

The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Albuminuria. The leading clinical trial sponsors are Keryx Biopharmaceuticals, Collaborative Study Group (CSG), and Corbridge Group Philippines, Inc.

There are seventy US patents protecting this investigational drug and four hundred and nine international patents.

Recent Clinical Trials for Sulodexide
TitleSponsorPhase
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)University Medical Center GroningenPhase 4
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)Steno Diabetes CenterPhase 4
Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and SulodexideBama GeVe, S.L.U.Phase 4

See all Sulodexide clinical trials

Clinical Trial Summary for Sulodexide

Top disease conditions for Sulodexide
Top clinical trial sponsors for Sulodexide

See all Sulodexide clinical trials

US Patents for Sulodexide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sulodexide   Start Trial Nucleic acid vaccines ModernaTX, Inc. (Cambridge, MA)   Start Trial
Sulodexide   Start Trial Polynucleotides encoding immune modulating polypeptides ModernaTX, Inc. (Cambridge, MA)   Start Trial
Sulodexide   Start Trial Human cytomegalovirus RNA vaccines ModernaTX, Inc. (Cambridge, MA)   Start Trial
Sulodexide   Start Trial Efficient protein expression in vivo using modified RNA (MOD-RNA) THE GENERAL HOSPITAL CORPORATION (Boston, MA) CHILDREN'S MEDICAL CENTER CORPORATION (Boston, MA)   Start Trial
Sulodexide   Start Trial Zika virus RNA vaccines ModernaTX, Inc. (Cambridge, MA)   Start Trial
Sulodexide   Start Trial Manufacturing methods for production of RNA transcripts ModernaTX, Inc. (Cambridge, MA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sulodexide

Drugname Country Document Number Estimated Expiration Related US Patent
Sulodexide Australia 2015249553 2034-04-23   Start Trial
Sulodexide Brazil 112016024644 2034-04-23   Start Trial
Sulodexide Canada 2946751 2034-04-23   Start Trial
Sulodexide China 106659803 2034-04-23   Start Trial
Sulodexide European Patent Office 3134131 2034-04-23   Start Trial
Sulodexide Japan 2017513956 2034-04-23   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
McKinsey
Dow
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.